![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 12, 10226-10235, March 22, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Laboratories for Reproductive Biology and the Departments
of Biochemistry and Biophysics, and Pediatrics, University of North
Carolina, Chapel Hill, North Carolina 27599
The androgen receptor (AR) activation function 2 region of the ligand binding domain binds the LXXLL motifs
of p160 coactivators weakly, engaging instead in an
androgen-dependent, interdomain interaction with an
FXXLF motif in the AR NH2 terminus. Here we show that FXXLF motifs are present in previously reported
AR coactivators ARA70/RFG, ARA55/Hic-5, and ARA54, which account for
their selection in yeast two-hybrid screens. Mammalian two-hybrid
assays, ligand dissociation rate studies, and glutathione
S-transferase adsorption assays indicate
androgen-dependent selective interactions of these FXXLF motifs with the AR ligand binding domain. Mutagenesis
of residues within activation function 2 indicates distinct but
overlapping binding sites where specificity depends on sequences within
and flanking the FXXLF motif. Mutagenesis of the
FXXLF motifs eliminated interaction with the ligand binding
domain but only modestly reduced AR coactivation in transcription
assays. The studies indicate that the FXXLF binding motif
is specific for the AR and mediates interactions both within the AR and
with coregulatory proteins.
The FXXLF Motif Mediates Androgen Receptor-specific
Interactions with Coregulators*
*
This work was supported by Public Health Service Grant
HD16910 from the NICHD, National Institutes of Health, by Cooperative Agreement U54-HD35041 as part of the Specialized Cooperative Centers Program in Reproductive Research of National Institutes of Health, by
United States Army Medical Research and Material Command Grant DAMD17-00-1-0094, and by the International Training and Research in
Population and Health Program supported by the Fogarty International Center and NICHD, National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: CB 7500, Rm. 374, Medical Sciences Research Bldg., University of North Carolina, Chapel
Hill, NC 27599. Tel.: 919-966-5168; Fax: 919-966-2203; E-mail:
emw@med.unc.edu.
This article has been cited by other articles:
![]() |
S. Kaulfuss, M. Grzmil, B. Hemmerlein, P. Thelen, S. Schweyer, J. Neesen, L. Bubendorf, A. G. Glass, H. Jarry, B. Auber, et al. Leupaxin, a Novel Coactivator of the Androgen Receptor, Is Expressed in Prostate Cancer and Plays a Role in Adhesion and Invasion of Prostate Carcinoma Cells Mol. Endocrinol., July 1, 2008; 22(7): 1606 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bai and E. M. Wilson Epidermal Growth Factor-Dependent Phosphorylation and Ubiquitinylation of MAGE-11 Regulates Its Interaction with the Androgen Receptor Mol. Cell. Biol., March 15, 2008; 28(6): 1947 - 1963. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bai, G. Grossman, L. Yuan, B. A. Lessey, F. S. French, S. L. Young, and E. M. Wilson Hormone control and expression of androgen receptor coregulator MAGE-11 in human endometrium during the window of receptivity to embryo implantation Mol. Hum. Reprod., February 1, 2008; 14(2): 107 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Peng, C. X. Li, F. Chen, Z. Wang, M. Ligr, J. Melamed, J. Wei, W. Gerald, M. Pagano, M. J. Garabedian, et al. Stimulation of Prostate Cancer Cellular Proliferation and Invasion by the Androgen Receptor Co-Activator ARA70 Am. J. Pathol., January 1, 2008; 172(1): 225 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. V. Heemers and D. J. Tindall Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex Endocr. Rev., December 1, 2007; 28(7): 778 - 808. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cantin, F. Faucher, J.-F. Couture, K. P. de Jesus-Tran, P. Legrand, L. C. Ciobanu, Y. Frechette, R. Labrecque, S. M. Singh, F. Labrie, et al. Structural Characterization of the Human Androgen Receptor Ligand-binding Domain Complexed with EM5744, a Rationally Designed Steroidal Ligand Bearing a Bulky Chain Directed toward Helix 12 J. Biol. Chem., October 19, 2007; 282(42): 30910 - 30919. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Askew, R. T. Gampe Jr., T. B. Stanley, J. L. Faggart, and E. M. Wilson Modulation of Androgen Receptor Activation Function 2 by Testosterone and Dihydrotestosterone J. Biol. Chem., August 31, 2007; 282(35): 25801 - 25816. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. van Royen, S. M. Cunha, M. C. Brink, K. A. Mattern, A. L. Nigg, H. J. Dubbink, P. J. Verschure, J. Trapman, and A. B. Houtsmuller Compartmentalization of androgen receptor protein-protein interactions in living cells J. Cell Biol., April 9, 2007; 177(1): 63 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Wilson Muscle-Bound? A Tissue-Selective Nonsteroidal Androgen Receptor Modulator Endocrinology, January 1, 2007; 148(1): 1 - 3. [Full Text] [PDF] |
||||
![]() |
S. Folkertsma, P. I. van Noort, A. de Heer, P. Carati, R. Brandt, A. Visser, G. Vriend, and J. de Vlieg The Use of in Vitro Peptide Binding Profiles and in Silico Ligand-Receptor Interaction Profiles to Describe Ligand-Induced Conformations of the Retinoid X Receptor {alpha} Ligand-Binding Domain Mol. Endocrinol., January 1, 2007; 21(1): 30 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J Burd, L. M Morey, and K. E Knudsen Androgen receptor corepressors and prostate cancer Endocr. Relat. Cancer, December 1, 2006; 13(4): 979 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Z. Lu, S. E. Wardell, K. L. Burnstein, D. Defranco, P. J. Fuller, V. Giguere, R. B. Hochberg, L. McKay, J.-M. Renoir, N. L. Weigel, et al. International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors Pharmacol. Rev., December 1, 2006; 58(4): 782 - 797. [Full Text] [PDF] |
||||
![]() |
S. M. Dehm and D. J. Tindall Ligand-independent Androgen Receptor Activity Is Activation Function-2-independent and Resistant to Antiandrogens in Androgen Refractory Prostate Cancer Cells J. Biol. Chem., September 22, 2006; 281(38): 27882 - 27893. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Dubbink, R. Hersmus, A. C. W. Pike, M. Molier, A. O. Brinkmann, G. Jenster, and J. Trapman Androgen Receptor Ligand-Binding Domain Interaction and Nuclear Receptor Specificity of FXXLF and LXXLL Motifs as Determined by L/F Swapping Mol. Endocrinol., August 1, 2006; 20(8): 1742 - 1755. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. van de Wijngaart, M. E. van Royen, R. Hersmus, A. C. W. Pike, A. B. Houtsmuller, G. Jenster, J. Trapman, and H. J. Dubbink Novel FXXFF and FXXMF Motifs in Androgen Receptor Cofactors Mediate High Affinity and Specific Interactions with the Ligand-binding Domain J. Biol. Chem., July 14, 2006; 281(28): 19407 - 19416. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, J. Fu, C. Toumazou, H.-G. Yoon, and J. Wong A Role of the Amino-Terminal (N) and Carboxyl-Terminal (C) Interaction in Binding of Androgen Receptor to Chromatin Mol. Endocrinol., April 1, 2006; 20(4): 776 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Estebanez-Perpina, J. M. R. Moore, E. Mar, E. Delgado-Rodrigues, P. Nguyen, J. D. Baxter, B. M. Buehrer, P. Webb, R. J. Fletterick, and R. K. Guy The Molecular Mechanisms of Coactivator Utilization in Ligand-dependent Transactivation by the Androgen Receptor J. Biol. Chem., March 4, 2005; 280(9): 8060 - 8068. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bai, B. He, and E. M. Wilson Melanoma Antigen Gene Protein MAGE-11 Regulates Androgen Receptor Function by Modulating the Interdomain Interaction Mol. Cell. Biol., February 15, 2005; 25(4): 1238 - 1257. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Hsu, Y.-L. Chen, H.-J. Ting, W.-J. Lin, Z. Yang, Y. Zhang, L. Wang, C.-T. Wu, H.-C. Chang, S. Yeh, et al. Androgen Receptor (AR) NH2- and COOH-Terminal Interactions Result in the Differential Influences on the AR-Mediated Transactivation and Cell Growth Mol. Endocrinol., February 1, 2005; 19(2): 350 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Brown and C. E. Turner Paxillin: Adapting to Change Physiol Rev, October 1, 2004; 84(4): 1315 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Dubbink, R. Hersmus, C. S. Verma, H. A. G. M. van der Korput, C. A. Berrevoets, J. van Tol, A. C. J. Ziel-van der Made, A. O. Brinkmann, A. C. W. Pike, and J. Trapman Distinct Recognition Modes of FXXLF and LXXLL Motifs by the Androgen Receptor Mol. Endocrinol., September 1, 2004; 18(9): 2132 - 2150. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Buchanan, M. Yang, A. Cheong, J. M. Harris, R. A. Irvine, P. F. Lambert, N. L. Moore, M. Raynor, P. J. Neufing, G. A. Coetzee, et al. Structural and functional consequences of glutamine tract variation in the androgen receptor Hum. Mol. Genet., August 15, 2004; 13(16): 1677 - 1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Hu, S. Yeh, S.-D. Yeh, E. R. Sampson, J. Huang, P. Li, C.-L. Hsu, H.-J. Ting, H.-K. Lin, L. Wang, et al. Functional Domain and Motif Analyses of Androgen Receptor Coregulator ARA70 and Its Differential Expression in Prostate Cancer J. Biol. Chem., August 6, 2004; 279(32): 33438 - 33446. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. He, S. Bai, A. T. Hnat, R. I. Kalman, J. T. Minges, C. Patterson, and E. M. Wilson An Androgen Receptor NH2-terminal Conserved Motif Interacts with the COOH Terminus of the Hsp70-interacting Protein (CHIP) J. Biol. Chem., July 16, 2004; 279(29): 30643 - 30653. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, C.-L. Hsu, J. Ni, P.-H. Wang, S. Yeh, P. Keng, and C. Chang Human Checkpoint Protein hRad9 Functions as a Negative Coregulator To Repress Androgen Receptor Transactivation in Prostate Cancer Cells Mol. Cell. Biol., March 1, 2004; 24(5): 2202 - 2213. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Gregory, X. Fei, L. A. Ponguta, B. He, H. M. Bill, F. S. French, and E. M. Wilson Epidermal Growth Factor Increases Coactivation of the Androgen Receptor in Recurrent Prostate Cancer J. Biol. Chem., February 20, 2004; 279(8): 7119 - 7130. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sathya, C.-y. Chang, D. Kazmin, C. E. Cook, and D. P. McDonnell Pharmacological Uncoupling of Androgen Receptor-mediated Prostate Cancer Cell Proliferation and Prostate-specific Antigen Secretion Cancer Res., November 15, 2003; 63(22): 8029 - 8036. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kasai, J. Guerrero-Santoro, R. Friedman, E. S. Leman, R. H. Getzenberg, and D. B. DeFranco The Group 3 LIM Domain Protein Paxillin Potentiates Androgen Receptor Transactivation in Prostate Cancer Cell Lines Cancer Res., August 15, 2003; 63(16): 4927 - 4935. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Hsu, Y.-L. Chen, S. Yeh, H.-J. Ting, Y.-C. Hu, H. Lin, X. Wang, and C. Chang The Use of Phage Display Technique for the Isolation of Androgen Receptor Interacting Peptides with (F/W)XXL(F/W) and FXXLY New Signature Motifs J. Biol. Chem., June 20, 2003; 278(26): 23691 - 23698. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-Z. Liu, H. Wang, and Z. Wang Identification of a Highly Conserved Domain in the Androgen Receptor That Suppresses the DNA-binding Domain-DNA Interactions J. Biol. Chem., April 18, 2003; 278(17): 14956 - 14960. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. He and E. M. Wilson Electrostatic Modulation in Steroid Receptor Recruitment of LXXLL and FXXLF Motifs Mol. Cell. Biol., March 15, 2003; 23(6): 2135 - 2150. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Li, H. Lee, S. Guo, T. G. Unterman, G. Jenster, and W. Bai AKT-Independent Protection of Prostate Cancer Cells from Apoptosis Mediated through Complex Formation between the Androgen Receptor and FKHR Mol. Cell. Biol., January 1, 2003; 23(1): 104 - 118. [Abstract] [Full Text] |
||||
![]() |
B. He, L. W. Lee, J. T. Minges, and E. M. Wilson Dependence of Selective Gene Activation on the Androgen Receptor NH2- and COOH-terminal Interaction J. Biol. Chem., July 5, 2002; 277(28): 25631 - 25639. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Gelmann Molecular Biology of the Androgen Receptor J. Clin. Oncol., July 1, 2002; 20(13): 3001 - 3015. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |